Topic: How To Invest

Power Growth Investor Hotline – Friday, June 17, 2022

Article Excerpt

RESMED INC., $197.57, is a buy. The firm, symbol RMD on New York, helps investors tap the growing market for medical devices used to treat sleep apnea. ResMed’s CPAP (nasal continuous positive airway pressure) medical devices are used to treat patients with chronic obstructive pulmonary disease as well as other respiratory conditions. With each new machine ResMed sells, it also acquires a potential long-term customer for replacement parts. They include tubing, masks and so on, which must be replaced several times a year and so provide steady recurring revenue. In addition, the company is a provider of cloud-based software health applications and devices enabling clinicians to manage more patients efficiently and effectively through connected-care devices, as well as enabling and encouraging patients’ long-term adherence to their therapy. ResMed also provides management software to agencies providing out-of-hospital care, including home medical equipment, home health and hospice care, skilled nursing, life plan community and senior living assistance. This week, the company announced that it has…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.